Outset Medical (OM) Stock Price

Outset Medical Price

NASDAQ·CLOSED
4.13USD+0.01 (+0.24 %)
Market closed

Revenue has compounded at 79.3% per year over the past 7 years to 119.48 M USD. Outset Medical's net margin stands at -68.3%, up from -128.6% several years earlier. Analysts set a median price target of 11.73 USD, implying 184.0% above the current price. Of 13 analysts, 10 rate the stock a buy — an overall Buy consensus. The stock trades about 31% above its 52-week low.

Outset Medical stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Outset Medical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Outset Medical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Outset Medical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Outset Medical Stock Price History
DateOutset Medical Price
7/22/20264.13 USD
7/21/20264.12 USD
7/20/20264.06 USD
7/17/20264.20 USD
7/16/20264.36 USD
7/15/20264.53 USD
7/14/20264.54 USD
7/13/20264.41 USD
7/10/20264.43 USD
7/9/20264.45 USD
7/8/20264.38 USD
7/7/20264.79 USD
7/6/20264.88 USD
7/2/20264.72 USD
7/1/20265.10 USD
6/30/20264.32 USD
6/29/20264.33 USD
6/26/20264.58 USD
6/25/20264.59 USD
6/24/20264.63 USD
6/23/20264.76 USD
6/22/20265.00 USD
6/18/20265.05 USD
6/17/20264.02 USD
6/16/20264.41 USD
6/15/20264.31 USD
6/12/20264.49 USD
6/11/20264.30 USD
6/10/20264.62 USD
6/9/20264.69 USD
6/8/20264.32 USD
6/5/20264.58 USD
6/4/20264.73 USD
6/3/20264.60 USD
6/2/20265.07 USD
6/1/20264.91 USD
5/29/20264.89 USD
5/28/20265.01 USD
5/27/20264.39 USD
5/26/20264.40 USD
5/22/20264.32 USD
5/21/20264.26 USD
5/20/20264.38 USD
5/19/20263.86 USD
5/18/20263.72 USD
5/15/20263.63 USD
5/14/20263.81 USD
5/13/20263.89 USD
5/12/20263.84 USD
5/11/20263.65 USD
5/8/20263.69 USD
5/7/20264.68 USD
5/6/20264.51 USD
5/5/20264.77 USD
5/4/20264.33 USD
5/1/20264.36 USD
4/30/20264.27 USD
4/29/20264.18 USD
4/28/20264.32 USD
4/27/20264.41 USD
4/24/20264.52 USD
4/23/20264.48 USD
4/22/20264.52 USD
4/21/20264.45 USD
4/20/20264.61 USD
4/17/20264.61 USD
4/16/20264.40 USD
4/15/20264.35 USD
4/14/20264.35 USD
4/13/20264.31 USD
4/10/20264.20 USD
4/9/20264.32 USD
4/8/20264.20 USD
4/7/20264.10 USD
4/6/20264.08 USD
4/2/20264.01 USD
4/1/20263.84 USD
3/31/20263.84 USD
3/30/20263.61 USD
3/27/20263.56 USD
3/26/20263.52 USD
3/25/20263.53 USD
3/24/20263.53 USD
3/23/20263.62 USD
3/20/20263.36 USD
3/19/20263.37 USD
3/18/20263.35 USD
3/17/20263.61 USD
3/16/20263.35 USD
3/13/20263.26 USD
3/12/20263.16 USD
3/11/20263.26 USD
3/10/20263.18 USD
3/9/20263.22 USD
3/6/20263.18 USD
3/5/20263.44 USD
3/4/20263.53 USD
3/3/20263.48 USD
3/2/20263.57 USD
2/27/20263.49 USD
2/26/20263.64 USD
2/25/20263.37 USD
2/24/20263.34 USD
2/23/20263.35 USD
2/20/20263.53 USD
2/19/20263.53 USD
2/18/20263.47 USD
2/17/20263.25 USD
2/13/20263.39 USD
2/12/20263.80 USD
2/11/20264.54 USD
2/10/20264.70 USD
2/9/20264.65 USD
2/6/20264.50 USD
2/5/20264.39 USD
2/4/20264.90 USD
2/3/20265.04 USD
2/2/20264.97 USD
1/30/20265.01 USD
1/29/20265.07 USD
1/28/20265.03 USD
1/27/20265.68 USD
1/26/20264.97 USD
1/23/20265.11 USD
1/22/20265.40 USD
1/21/20265.20 USD
1/20/20265.05 USD
1/16/20265.30 USD
1/15/20265.26 USD
1/14/20265.48 USD
1/13/20265.12 USD
1/12/20265.57 USD
1/9/20264.56 USD
1/8/20264.67 USD
1/7/20264.34 USD
1/6/20264.29 USD
1/5/20263.80 USD
1/2/20263.70 USD
12/31/20253.71 USD
12/30/20253.62 USD
12/29/20253.54 USD
12/26/20253.36 USD
12/24/20253.29 USD
12/23/20253.32 USD
12/22/20253.68 USD
12/19/20253.70 USD
12/18/20253.61 USD
12/17/20253.77 USD
12/16/20253.92 USD
12/15/20253.97 USD
12/12/20254.18 USD
12/11/20254.29 USD
12/10/20254.40 USD
12/9/20254.36 USD
12/8/20254.34 USD
12/5/20254.39 USD
12/4/20254.72 USD
12/3/20254.31 USD
12/2/20254.05 USD
12/1/20254.22 USD
11/28/20254.56 USD
11/26/20254.44 USD
11/25/20254.47 USD
11/24/20254.33 USD
11/21/20254.29 USD
11/20/20254.44 USD
11/19/20254.57 USD
11/18/20254.97 USD
11/17/20254.92 USD
11/14/20254.68 USD
11/13/20254.90 USD
11/12/20255.54 USD
11/11/20256.22 USD
11/10/20256.22 USD
11/7/20256.21 USD
11/6/20256.09 USD
11/5/20256.47 USD
11/4/20256.58 USD
11/3/20256.70 USD
10/31/20256.76 USD
10/30/20256.51 USD
10/29/20256.95 USD
10/28/20257.32 USD
10/27/20257.41 USD
10/24/20257.60 USD
10/23/20257.83 USD
10/22/20257.76 USD
10/21/20257.87 USD
10/20/20258.00 USD
10/17/20256.83 USD
10/16/20256.87 USD
10/15/20256.99 USD
10/14/20256.90 USD
10/13/20256.50 USD
10/10/20256.42 USD
10/9/20257.79 USD
10/8/20258.15 USD
10/7/20257.74 USD
10/6/20257.67 USD
10/3/20257.47 USD
10/2/20257.26 USD
10/1/20257.22 USD
9/30/20257.28 USD
9/29/20257.47 USD
9/26/20257.48 USD
9/25/20257.58 USD
9/24/20257.62 USD
9/23/20257.65 USD
9/22/20258.13 USD
9/19/20257.31 USD
9/18/20257.30 USD
9/17/20257.18 USD
9/16/20257.14 USD
9/15/20257.07 USD
9/12/20257.05 USD
9/11/20257.29 USD
9/10/20256.98 USD
9/9/20257.31 USD
9/8/20257.12 USD
9/5/20257.22 USD
9/4/20256.88 USD
9/3/20257.10 USD
9/2/20257.08 USD
8/29/20257.17 USD
8/28/20257.17 USD
8/27/20257.19 USD
8/26/20257.27 USD
8/25/20257.07 USD
8/22/20257.32 USD
8/21/20257.04 USD
8/20/20256.87 USD
8/19/20256.88 USD
8/18/20257.04 USD
8/15/20256.85 USD
8/14/20256.64 USD
8/13/20256.81 USD
8/12/20256.53 USD
8/11/20256.41 USD
8/8/20256.60 USD
8/7/20257.31 USD
8/6/20256.79 USD
8/5/20257.27 USD
8/4/20257.30 USD
8/1/20257.75 USD
7/31/20258.28 USD
7/30/20258.71 USD
7/29/20259.04 USD
7/28/20259.30 USD
Access this data via the Eulerpool API
Get Free API Key

Outset Medical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
49.94 M USD
-119.13 M USD
-120.70 M USD
Jan 1, 2021
102.60 M USD
-130.52 M USD
-131.94 M USD
Jan 1, 2022
115.38 M USD
-162.39 M USD
-162.96 M USD
Jan 1, 2023
130.38 M USD
-169.77 M USD
-172.80 M USD
Jan 1, 2024
113.69 M USD
-113.38 M USD
-127.98 M USD
Jan 1, 2025
119.48 M USD
-74.39 M USD
-81.65 M USD
Jan 1, 2026 (e)
125.73 M USD
-43.59 M USD
-52.88 M USD
Jan 1, 2027 (e)
139.27 M USD
-37.87 M USD
-39.63 M USD

Outset Medical Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 25, 2026, 7:05 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201820192020202120222023202420252026e2027e
2.0015.0049.00102.00115.00130.00113.00119.00125.00139.00
–650.00226.67108.1612.7513.04-13.085.315.0411.20
-300.00-113.33-26.536.8614.7822.3133.6338.6638.6638.66
-6.00-17.00-13.007.0017.0029.0038.0046.0048.3253.73
-46.00-70.00-119.00-130.00-162.00-169.00-113.00-74.00-43.00-37.00
-2,300.00-466.67-242.86-127.45-140.87-130.00-100.00-62.18-34.40-26.62
-49.00-68.00-120.00-131.00-162.00-172.00-127.00-81.00-52.00-39.00
–38.7876.479.1723.666.17-26.16-36.22-35.80-25.00
17.822.012.853.143.233.353.4217.8217.8217.82
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Outset Medical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Outset Medical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Outset Medical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Outset Medical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Outset Medical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Outset Medical stock margins

The Outset Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Outset Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Outset Medical.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
-26.11 %
-238.56 %
-241.71 %
Jan 1, 2021
7.42 %
-127.21 %
-128.59 %
Jan 1, 2022
15.46 %
-140.75 %
-141.24 %
Jan 1, 2023
22.24 %
-130.22 %
-132.54 %
Jan 1, 2024
33.92 %
-99.72 %
-112.57 %
Jan 1, 2025
39.13 %
-62.26 %
-68.34 %
Jan 1, 2026 (e)
39.13 %
-34.67 %
-42.05 %
Jan 1, 2027 (e)
39.13 %
-27.19 %
-28.45 %

Outset Medical Stock Revenue, EBIT, Earnings per Share

The Outset Medical earnings per share therefore indicates how much revenue Outset Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
17.54 USD
-41.83 USD
-42.38 USD
Jan 1, 2021
32.63 USD
-41.51 USD
-41.96 USD
Jan 1, 2022
35.78 USD
-50.35 USD
-50.53 USD
Jan 1, 2023
38.91 USD
-50.67 USD
-51.58 USD
Jan 1, 2024
33.29 USD
-33.20 USD
-37.47 USD
Jan 1, 2025
6.71 USD
-4.18 USD
-4.58 USD
Jan 1, 2026 (e)
6.93 USD
-2.45 USD
-2.91 USD
Jan 1, 2027 (e)
7.67 USD
-2.13 USD
-2.18 USD

Outset Medical business model & stock analysis

Outset Medical Segments

Outset Medical Revenue by Segment (1/2)

  • 3 Years

  • 5 Years

  • Max

Product Revenue
Product
Service and Other Revenue
Details
Date
Product Revenue
Product
Service and Other Revenue
Jan 1, 2020
39.61 M USD
0.00 USD
10.32 M USD
Jan 1, 2021
0.00 USD
84.31 M USD
18.29 M USD
Jan 1, 2022
93.39 M USD
0.00 USD
21.99 M USD
Jan 1, 2024
0.00 USD
80.98 M USD
32.71 M USD
Jan 1, 2025
0.00 USD
84.81 M USD
34.67 M USD

Outset Medical Revenue by Segment (2/2)

  • 3 Years

  • 5 Years

  • Max

Consumables Product
Consoles Product
Details
Date
Consumables Product
Consoles Product
Jan 1, 2020
6.74 M USD
3.10 M USD
Jan 1, 2021
19.18 M USD
65.13 M USD
Jan 1, 2022
28.80 M USD
64.59 M USD
Jan 1, 2024
51.15 M USD
29.83 M USD
Jan 1, 2025
54.08 M USD
30.73 M USD

Outset Medical Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Outset Medical historical P/E ratio, EBIT multiple, and P/S ratio

Outset Medical annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Outset Medical shares outstanding

The number of shares of Outset Medical was 17.82 M in 2025. This indicates how many shares Outset Medical is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
2.85 M Stocks
Jan 1, 2021
3.14 M Stocks
Jan 1, 2022
3.23 M Stocks
Jan 1, 2023
3.35 M Stocks
Jan 1, 2024
3.42 M Stocks
Jan 1, 2025
17.82 M Stocks
Jan 1, 2026 (e)
17.82 M Stocks
Jan 1, 2027 (e)
17.82 M Stocks

Outset Medical stock splits

In Outset Medical's history, there have been no stock splits.

Current Outset Medical forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy76.92 % (10)
Hold23.08 % (3)
Sell0.00 % (0)
12M Price Target
11.73
Last Price
4.23
Currency
USD
12M Return Potential
177.30 %
LTM Return
0 %

Outset Medical Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
8/4/2026-0.74USD30.73 MUSD2026 Q2
5/5/2026-0.82USD29.77 MUSD2026 Q1
2/11/2026-0.66USD27.45 MUSD2025 Q4
1/5/2026-0.66USD26.93 MUSD2025 Q4
5/1/2024-0.54USD33.57 MUSD2024 Q1
2/12/2024-0.63USD31.03 MUSD2023 Q4
7/31/2023-0.68USD35.35 MUSD2023 Q2
5/2/2023-0.67USD32.40 MUSD2023 Q1
2/14/2023-0.82USD29.51 MUSD2022 Q4
11/8/2022-0.83USD25.60 MUSD2022 Q3

EESG©

Eulerpool ESG Scorecard© for the Outset Medical stock

32/100
11
Environment
48
Social
36
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees33.8
Percentage of women in management—
Percentage of Asian employees21
Share of Asian management30.4
Percentage of Hispanic/Latino employees9
Hispano/Latino Management share1.8
Percentage of Black employees7.3
Black Management Share1.8
Percentage of white employees60.2
White Management Share62.5
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Outset Medical shareholder structure

% Name
14.15970%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
9.17205%
PFM Health Sciences, LP
PFM Health Sciences, LP
9.13017%
Durable Capital Partners LP
Durable Capital Partners LP
8.94510%
T. Rowe Price Investment Management, Inc.
T. Rowe Price Investment Management, Inc.
8.06932%
Alyeska Investment Group, L.P.
Alyeska Investment Group, L.P.
7.30460%
Woodline Partners LP
Woodline Partners LP
...

Outset Medical Executives and Management Board

LT

Ms. Leslie Trigg

(54)

Chairman of the Board, President, Chief Executive Officer · since 2014

Compensation4.00 M USD
JB

Mr. John Brottem

(51)

General Counsel, Secretary

Compensation1.51 M USD
BL

Mr. Brent Lang

(57)

Independent Director

Compensation402,923.00 USD
DG

Mr. D. Keith Grossman

(65)

Lead Independent Director

Compensation200,000.00 USD
PH

Mr. Patrick Hackett

(63)

Independent Director

Compensation160,571.00 USD

Outset Medical Supply Chain

Outset Medical Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#Name1M3M6M1Y2YTrend
1
Carlisle Cos
Supplier
0.83
-0.23
-0.06
-0.36
—

Frequently asked questions about Outset Medical

Analysts currently set an average price target of 11.99 USD for the Outset Medical stock (median: 11.73 USD), implying +183.3 % versus the latest price. The consensus is based on 13 analyst ratings.

Outset Medical Analyst Price Targets 2026

All fundamentals and in-depth analysis of Outset Medical

Our stock analysis for Outset Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Outset Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Outset Medical Stock
Outset Medical Revenue→
Outset Medical Stock
Outset Medical Net Income→
Outset Medical Stock
Outset Medical P/E→
Outset Medical Stock
Outset Medical P/S→
Outset Medical Stock
Outset Medical EBIT→
Outset Medical Stock
Outset Medical Dividend→
Outset Medical Stock
Outset Medical Directors Dealings→
Outset Medical Stock
Outset Medical Stocks→
Outset Medical Stock
Outset Medical Market capitalization→
Outset Medical Stock
Outset Medical Debt→
Outset Medical Stock
Outset Medical Liabilities→
Outset Medical Stock
Outset Medical Equity→
Outset Medical Stock
Outset Medical AAQS→
Outset Medical Stock
Outset Medical Employees→
Outset Medical Stock
Outset Medical ROE→
Outset Medical Stock
Outset Medical ROA→
Outset Medical Stock
Outset Medical ROCE→
Outset Medical Stock
Outset Medical News→
Outset Medical Stock
Outset Medical Analyst Price Targets→

Health Stocks

Ovid TherapeuticsOurofinoOwletOUE HealthcareOxford BiomedicaOttobock SE & Co KgaAOxford Nanopore TechnologiesOtsuka Holdings CoOxurionOstrom Climate SolutionsP&K Skin Research Center CoOsteoporeAll Stocks A–Z →